Scotland · NHS Scotland MSAN
Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and
MSAN(2024)40 · Level 2 · issued 28 Jun 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Disopyramide (Rythmodan Retard®) 250mg modified-release tablets are out of stock until mid | Out of stock | mid |
| 2. Disopyramide (Rythmodan®) 100mg capsules will be out of stock from mid-July 2024 until mid | Out of stock | mid |
| 4. Alternative treatments to disopyramide remain available (see Additional information). | Available | — |
| 6. Unlicensed specials of disopyramide 25mg/5ml & 50mg/5ml oral suspension are available, lead | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.